Subscribe to RSS
DOI: 10.1055/s-0035-1552939
Differential Morbidity in Preterm Small versus Appropriate for Gestational Age: Perhaps Unverifiable
Publication History
21 November 2014
03 April 2015
Publication Date:
29 May 2015 (online)
![](https://www.thieme-connect.de/media/ajp/201513/lookinside/thumbnails/10-1055-s-0035-1552939_140367-1.jpg)
Abstract
Objective The objective of this study was to determine the morbidity of preterm small for gestational age (SGA) infants compared with appropriate for GA (AGA).
Study Design This is a secondary analysis of the randomized trial evaluating magnesium sulfate for the prevention of cerebral palsy (CP). We compared outcomes of preterm (< 37 weeks) nonanomalous infants who were SGA (birth weight < 10% for GA) versus AGA (birth weight 10–89% for GA). We compared (1) the parent trial primary outcome, a composite of stillbirth, infant death by 1 year of age, or moderate to severe CP at 2 years of age and (2) composite neonatal morbidity (CNM).
Results Of the 1,948 infants who met inclusion criteria, 95% were AGA and 5% were SGA. The primary outcome was similar (10 and 15%, p = 0.08), as was the CNM (24 and 25%, p = 0.89). Sample size calculations indicate that detection of a one-third higher rate of CNM among SGA compared with AGA infants requires more than 93,900 preterm births; for a one-third difference in moderate to severe CP, more than 1.4 million infants.
Conclusion Owing to the prohibitive sample size required, ascertaining a difference in sequela between preterm SGA and AGA infants is possibly unverifiable.
-
References
- 1 American College of Obstetrics and Gynecologists. ACOG Practice bulletin no. 134: fetal growth restriction. Obstet Gynecol 2013; 121 (5) 1122-1133
- 2 Royal College of Obstetricians and Gynaecologists. The Investigation and Management of Small-for-Gestational-Age Fetus. Green–Top Guideline no. 31. London: RCOG; 2013
- 3 Lausman A, Kingdom J, Gagnon R , et al; Maternal Fetal Medicine Committee. Intrauterine growth restriction: screening, diagnosis, and management. J Obstet Gynaecol Can 2013; 35 (8) 741-757
- 4 McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999; 340 (16) 1234-1238
- 5 Garite TJ, Clark R, Thorp JA. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstet Gynecol 2004; 191 (2) 481-487
- 6 Chen HY, Chauhan SP, Ward TC, Mori N, Gass ET, Cisler RA. Aberrant fetal growth and early, late, and postneonatal mortality: an analysis of Milwaukee births, 1996-2007. Am J Obstet Gynecol 2011; 204 (3) 261.e1-261.e10
- 7 O'Callaghan ME, MacLennan AH, Gibson CS , et al; Australian Collaborative Cerebral Palsy Research Group. Epidemiologic associations with cerebral palsy. Obstet Gynecol 2011; 118 (3) 576-582
- 8 Arends NJ, Boonstra VH, Hokken-Koelega AC. Head circumference and body proportions before and during growth hormone treatment in short children who were born small for gestational age. Pediatrics 2004; 114 (3) 683-690
- 9 Berghella V. Prevention of recurrent fetal growth restriction. Obstet Gynecol 2007; 110 (4) 904-912
- 10 Rasmussen S, Irgens LM, Skjaerven R, Melve KK. Prior adverse pregnancy outcome and the risk of stillbirth. Obstet Gynecol 2009; 114 (6) 1259-1270
- 11 Williams RL, Creasy RK, Cunningham GC, Hawes WE, Norris FD, Tashiro M. Fetal growth and perinatal viability in California. Obstet Gynecol 1982; 59 (5) 624-632
- 12 Rouse DJ, Hirtz DG, Thom E , et al; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008; 359 (9) 895-905
- 13 Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003; 3: 6
- 14 Manuck TA, Varner MW. Neonatal and early childhood outcomes following early vs later preterm premature rupture of membranes. Am J Obstet Gynecol 2014; 211 (3) 308.e1-308.e6
- 15 Wilcox AJ, Weinberg CR, Basso O. On the pitfalls of adjusting for gestational age at birth. Am J Epidemiol 2011; 174 (9) 1062-1068
- 16 Ananth CV, VanderWeele TJ. Placental abruption and perinatal mortality with preterm delivery as a mediator: disentangling direct and indirect effects. Am J Epidemiol 2011; 174 (1) 99-108
- 17 Basso O, Wilcox AJ. Might rare factors account for most of the mortality of preterm babies?. Epidemiology 2011; 22 (3) 320-327
- 18 VanderWeele TJ, Mumford SL, Schisterman EF. Conditioning on intermediates in perinatal epidemiology. Epidemiology 2012; 23 (1) 1-9
- 19 von Elm E, Altman DG, Egger M , et al; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. Int J Surg 2014; 12 (12) 1495-1499
- 20 Grobman WA, Lai Y, Rouse DJ , et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. The association of cerebral palsy and death with small-for-gestational-age birthweight in preterm neonates by individualized and population-based percentiles. Am J Obstet Gynecol 2013; 209 (4) 340.e1-340.e5
- 21 Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customised antenatal growth charts. Lancet 1992; 339 (8788) 283-287
- 22 Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996; 87 (2) 163-168